Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$225K |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
$208K |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$176K |
| 4 |
Tesla
TSLA
|
$176K |
| 5 |
Meta Platforms (Facebook)
META
|
$174K |
Top Sells
| 1 |
TECD
Tech Data Corp
TECD
|
$186M |
| 2 |
MINI
Mobile Mini Inc
MINI
|
$92.3M |
| 3 |
Canadian Pacific Kansas City
CP
|
$91.9M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
$77.9M |
| 5 |
Kraft Heinz
KHC
|
$60.1M |
Sector Composition
| 1 | Healthcare | 15.67% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Technology | 11.33% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
401
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $27.7K | 0.03% |
242,065
-136,878
| -36% | -$15.7K |
|
402
Apellis Pharmaceuticals
APLS
$3.55B
| $27.7K | 0.03% |
916,703
-158,547
| -15% | -$4.78K |
|
403
Western Union
WU
$2.86B
| $27.6K | 0.03% |
1,289,950
-147,250
| -10% | -$3.16K |
|
404
Health Care Select Sector SPDR Fund
XLV
$34B
| $27.6K | 0.03% |
261,903
-240,964
| -48% | -$25.4K |
|
|
CMLFU
405
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $27.6K | 0.03% |
+2,632,318
| New | +$27.6K |
|
406
IDEX
IEX
$12.4B
| $27.6K | 0.03% |
151,066
+168
| +0.1% | +$31 |
|
407
SI-BONE Inc
SIBN
$703M
| $27.5K | 0.03% |
1,159,768
-29,716
| -2% | -$705 |
|
|
RETA
408
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $27.5K | 0.03% |
282,007
-36,170
| -11% | -$3.52K |
|
|
CNH
409
CNH Industrial
CNH
$14.3B
| $27.4K | 0.03% |
4,023,228
+3,402,700
| +548% | +$23.2K |
|
410
Kellanova
K
$27.8B
| $27.3K | 0.03% |
450,824
+440,031
| +4,077% | +$26.7K |
|
411
Citizens Financial Group
CFG
$22.3B
| $27.3K | 0.03% |
1,078,152
-78,528
| -7% | -$1.99K |
|
412
Sherwin-Williams
SHW
$92.9B
| $27.2K | 0.03% |
117,141
-267,009
| -70% | -$62K |
|
413
Middleby
MIDD
$7.32B
| $27.1K | 0.03% |
302,497
+217,633
| +256% | +$19.5K |
|
414
Advantage Solutions
ADV
$580M
| $27.1K | 0.03% |
2,670,310
+921,710
| +53% | +$9.37K |
|
|
NAV
415
DELISTED
Navistar International
NAV
| $27K | 0.03% |
621,110
+235,001
| +61% | +$10.2K |
|
416
Allison Transmission
ALSN
$7.53B
| $26.8K | 0.03% |
763,000
-690,416
| -48% | -$24.3K |
|
417
W.W. Grainger
GWW
$47.5B
| $26.8K | 0.03% |
75,077
-3,044
| -4% | -$1.09K |
|
418
Iovance Biotherapeutics
IOVA
$901M
| $26.7K | 0.03% |
811,645
+224,136
| +38% | +$7.38K |
|
419
DocuSign
DOCU
$16.1B
| $26.6K | 0.03% |
123,725
+50,374
| +69% | +$10.8K |
|
420
Corning
GLW
$61B
| $26.3K | 0.03% |
812,333
+579,686
| +249% | +$18.8K |
|
|
EVRI
421
DELISTED
Everi Holdings
EVRI
| $26.3K | 0.03% |
3,183,815
+302,005
| +10% | +$2.49K |
|
422
Herbalife
HLF
$1.02B
| $26.2K | 0.03% |
561,317
+224,679
| +67% | +$10.5K |
|
|
DOYU
423
DouYu International Holdings
DOYU
$234M
| $26.2K | 0.03% |
198,014
+149,062
| +305% | +$19.7K |
|
424
TSMC
TSM
$1.26T
| $26.1K | 0.03% |
322,319
-44,692
| -12% | -$3.62K |
|
425
Roper Technologies
ROP
$55.8B
| $26K | 0.03% |
65,877
-76,929
| -54% | -$30.4K |
|